Skip to Main Content
About
Pipeline
Platform
Investors
Careers
Our Team
Partnering
News & Events
Contact Us
ABCL635
ABCL575
Targets and Modalities
Publications
Current Openings
Partnering
News & Events
Contact Us
Clinical Trials
Publications
Current Openings
About
Our Team
Partnering
News & Events
Contact Us
Pipeline
ABCL635
ABCL575
Platform
Targets and Modalities
Publications
Investors
Careers
Current Openings
604.559.9005
Get in touch
News & events.
Our news.
Filter by Category
Filter by Category
News
Event
Text Link
Filter by Year
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Link 1
Filter by Category
News
Event
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
November 18, 2020
2020
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
Read article
News
November 18, 2020
2020
John Montalbano Joins AbCellera's Board of Directors
Read article
Event
November 17, 2020
2020
Antibody Engineering and Therapeutics US 2020
Read article
News
November 10, 2020
2020
AbCellera-Discovered Antibody Receives U.S. FDA Emergency Use Authorization as a Monotherapy for the Treatment of COVID-19
Read article
News
October 29, 2020
2020
AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
Read article
Event
October 28, 2020
2020
The 11th Annual Don Rix Distinguished Keynote Address
Read article
Event
October 23, 2020
2020
PEGS Europe Virtual 2020
Read article
News
September 28, 2020
2020
Fierce Biotech Names AbCellera a “Fierce 15” Company of 2020
Read article
News
September 24, 2020
2020
AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration
Read article
News
September 16, 2020
2020
Interim Data Reported for AbCellera-Discovered COVID-19 Antibody in Phase 2 Clinical Trials
Read article
1